Skip to main content

Medicinova Inc

MNOV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001226616

In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Medicinova Inc changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of MNOV: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders3533−2
Shares4.68M4.79M+112.2K (+2.4%)
Value$6.78M$7.04M+$263.6K (+3.9%)

New holders (5)

Institutions that held Medicinova Inc at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to MNOV in Q2 2024
InstitutionSharesValue% of portfolio
Bank of Montreal132,230$337.2K0.00%
Charles Schwab Investment Management Inc134,793$194.1K0.00%
Susquehanna International Group, LLP11,199$16.1K0.00%
Advisor Group Holdings, Inc.2,500$3.60K0.00%
Mather Group, LLC.50$730.00%

Sold out (7)

Institutions that held Medicinova Inc at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of MNOV in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Squarepoint Ops LLC14,856$21.5K
XTX Topco Ltd13,127$19.0K
Jane Street Group, LLC11,563$16.8K
FMR LLC1,202$1.74K
Wells Fargo & Company383$555
Morgan Stanley44$64
Group One Trading, L.P.1$1